PORCILIS M HYO ID ONCE EMULSION FOR INJECTION FOR PIGS

País: Irlanda

Idioma: inglés

Fuente: HPRA (Health Products Regulatory Authority)

Ingredientes activos:

INACTIVATED WHOLE CELL CONCENTRATE OF M. HYOPNEUMONIAE STRAIN 11

Disponible desde:

Intervet Ireland Limited

Código ATC:

QI09AB13

Designación común internacional (DCI):

INACTIVATED WHOLE CELL CONCENTRATE OF M. HYOPNEUMONIAE STRAIN 11

Dosis:

Unknown

formulario farmacéutico:

Emulsion for Injection

tipo de receta:

POM

Grupo terapéutico:

Porcine

Área terapéutica:

Mycoplasma vaccine

indicaciones terapéuticas:

Immunological - Inactivated vaccine

Estado de Autorización:

Authorised

Fecha de autorización:

2012-01-20

Ficha técnica

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Porcilis M Hyo ID ONCE emulsion for injection for pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One dose of 0.2 ml contains:
ACTIVE SUBSTANCE:
_Mycoplasma hyopneumoniae_ inactivated_,_ strain 11:
6.5 log
2
Ab titre*
* Mean antibody titre (Ab) obtained after inoculation of mice with a
1/1,000 pig dose.
ADJUVANT:
light liquid paraffin
34.6 mg
dl-
-tocopheryl acetate
2.5 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Emulsion for injection.
White to nearly white emulsion with creamy appearance after shaking.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunisation of pigs to reduce pulmonary lesions and
the decrease in daily weight gain during the
finishing period due to infection caused by_ Mycoplasma
hyopneumoniae_.
Onset of immunity: 3 weeks after vaccination.
Duration of immunity: 22 weeks after vaccination.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_0_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_5_
_7_
_6_
_8_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Vaccinate healthy animals only.
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
To the user:
This